Generic Name Brand Name

Date ordered , taken/given Date changed, D/C

Route of administration Dosage/Frequency

General action/ Classification/ Mechanism of action

Indication Purpose

Patients response

Nursing responsibilities

Ferrous Sulfate 05-22-13 Route of administration: Oral General action: Provides and replaces elemental iron, an essential component in formation of haemoglobin in red blood cell development. Indication/s: Prevention and treatment of irondeficiency anemia.

Dosage:

Frequency: TID

Obtain baseline assessment of iron deficiency before starting theraphy. Evaluate haemoglobin, hematocrit and reticulocyte count during theraphy. Monitor for adverse reaction Assess bowel elimination, increase water, bulk and activity if constipation occurs. Assess diet and nutrition amount of iron in diet(meat, dark green leafy vegetables, dried beans, dried fruits,eggs) Identify cause of iron loss or anemia Assess patients and family knowledge of drug theraphy.

Generic Name Brand Name

Date ordered , taken/given Date changed, D/C

Route of administration Dosage/Frequency

General action/ Classification/ Mechanism of action

Indication Purpose

Patients response

Nursing responsibilities

Furosemide Route of administration: TIV Inhibits reabsorption of sodium and chloride electrolytic and water balance primarily in loop of agent; loop diuretic Henle and also in proximal and distal renal tubules; Mechanism of Action: an antihypertensive that Rapid-acting potent decreases edema and sulfonamide loop intravascular volume. diuretic andantihypertensive with Reportedly less pharmacologic effects and uses ototoxic than almost identical to those of ethacrynic acid ethacrynic acid. Exact mode of action not clearly defined; decreases renal vascular resistance and may increase renal blood flow. Classification:

Dosage: 40mg

Frequency: q6

Give in morning to avoid interference of sleep Instruct patient to take with food if GI symptoms of nausea and anorexia occurs Inform patient that this drug causes a loss of potassium, therefore food rich in potassium should be added to the diet Instruct patient to lie down if dizziness occur Instruct patient to avoid replacing fluid losses with large amounts of water..

Generic Name Brand Name

Date ordered , taken/given Date changed, D/C

Route of administration Dosage/Frequency

General action/ Classification/ Mechanism of action

Indication Purpose

Patients response

Nursing responsibilities

Apirin Route of administration: Oral

Classification:

Antipyretic Analgesic Anti-inflammatory Antiplatelet Salicylate

Dosage: 80mg/tab

Mechanism of Action: inhibition of platelet aggregation is attributable to the inhibition of platelet synthesis of thromboxane A2, a potent vasoconstrictor and inducer of platelet aggregation. This effect occurs at low doses and lasts for the life of the platelet (8 days).

Frequency: OD

Mild to moderate pain Fever Inflammatory condition Reduction of risk of recurrent TIAs or stroke in males with history of TIA due to fibrin platelet emboli Reduction of risk of death or nonfatal MI in patients with history of infarction or unstable angina pectoris MI prophylaxis Unlabeled use: Prophylaxis against cataract formation with long-term use

Give drug with food or after meals if GI upset occurs. Give drug with full glass of water to reduce risk of tablet or capsule lodging in the esophagus. Do not crush, and ensure that patient does not chew SR preparations. Do not use aspirin that has a strong vinegar-like odor. Instruct patient to report ringing in the ears; dizziness, confusion; abdominal pain; rapid or difficult breathing; nausea, vomiting, bloody stools.

Generic Name Brand Name

Date ordered , taken/given Date changed, D/C

Route of administration Dosage/Frequency

General action/ Classification/ Mechanism of action

Indication Purpose

Patients response

Nursing responsibilities

Clonidine Route of administration: oral

Classification: Antihypertensive, Sympatholytic (centrally acting), Central analgesic Mechanism of Action: Dosage: 75mg/tab Clonidine stimulates alpha-2 receptors in brain stem which results in reduced sympathetic outflow from the CNS and a decrease in peripheral resistance leading to reduced BP and pulse rate. It does not alter normal hemodynamic response to exercise at recommended dosages

Hypertension, used alone or as part of combination therapy Treatment of severe pain in cancer patients in combination with opiates; epidural more effective with neuropathic pain (Duraclon)

Frequency:

Monitor BP carefully Do not discontinue abruptly; discontinue therapy by reducing the dosage gradually over 24 days to avoid rebound hypertension, tachycardia, flushing, nausea, vomiting, cardiac arrhythmias Take this drug exactly as prescribed Report urinary retention, changes in vision, blanching of fingers, rash.

Generic Name Brand Name

Date ordered , taken/given Date changed, D/C

Route of administration Dosage/Frequency Route of administration: oral

General action/ Classification/ Mechanism of action

Indication Purpose

Patients response

Nursing responsibilities

Ketoanalogue

Dosage: 600mg/tab

Frequency: TID